Analysis of the Pdcd4 expression level in a panel of NCI-60 cancer cell lines suggested that Pdcd4 protein level contributes to cellular sensitivity to tamoxifen and geldanamycin [4]. This evidence concerns the gene PDCD4 and cancer.